Guanylyl Cyclase C Suppresses Intestinal Tumorigenesis by Restricting Proliferation and Maintaining Genomic Integrity

Gastroenterology

Volumn 133, Issue 2, 2007, Pages 599-607

  Li, Peng ^a   Schulz, Stephanie ^a   Bombonati, Alessandro ^c   Palazzo, Juan P ^c   Hyslop, Terry M ^b   Xu, Yihuan ^b   Baran, Amy A ^c   Siracusa, Linda D ^c   Pitari, Giovanni M ^a   Waldman, Scott A ^a  

^a Division of Clinical Pharmacology   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; ENTEROTOXIN; ESCHERICHIA COLI ENTEROTOXIN; GUANYLATE CYCLASE; GUANYLYL CYCLASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DNA DAMAGE; FLUID BALANCE; GENE MUTATION; GENETIC STABILITY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL;

EID: 34547531854     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.05.052     Document Type: Article

References (35)

1. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., and Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52 (2000) 375-414
2. Li P, Lin JE, Chervoneva I, Schulz S, Waldman SA, Pitari GM. Homeostatic control of the crypt-villus axis by guanylyl cyclase C restricts the proliferating compartment in intestine. Submitted 2007.
3. Steinbrecher K.A., Wowk S.A., Rudolph J.A., Witte D.P., and Cohen M.B. Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am J Pathol 161 (2002) 2169-2178
4. Steinbrecher K.A., Tuohy T.M., Heppner Goss K., Scott M.C., Witte D.P., Groden J., and Cohen M.B. Expression of guanylin is downregulated in mouse and human intestinal adenomas. Biochem Biophys Res Commun 273 (2000) 225-230
5. Mann E.A., Steinbrecher K.A., Stroup C., Witte D.P., Cohen M.B., and Giannella R.A. Lack of guanylyl cyclase C, the receptor for Escherichia coli heat-stable enterotoxin, results in reduced polyp formation and increased apoptosis in the multiple intestinal neoplasia (Min) mouse model. Int J Cancer 116 (2005) 500-505
6. Shailubhai K., Yu H.H., Karunanandaa K., Wang J.Y., Eber S.L., Wang Y., Joo N.S., Kim H.D., Miedema B.W., Abbas S.Z., Boddupalli S.S., Currie M.G., and Forte L.R. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 60 (2000) 5151-5157
7. Pitari G.M., Zingman L.V., Hodgson D.M., Alekseev A.E., Kazerounian S., Bienengraeber M., Hajnoczky G., Terzic A., and Waldman S.A. Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci U S A 100 (2003) 2695-2699
8. Pitari G.M., Di Guglielmo M.D., Park J., Schulz S., and Waldman S.A. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci U S A 98 (2001) 7846-7851
9. Notterman D.A., Alon U., Sierk A.J., and Levine A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61 (2001) 3124-3130
10. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., and Kinzler K.W. Gene expression profiles in normal and cancer cells. Science 276 (1997) 1268-1272
11. Schulz S., Lopez M.J., Kuhn M., and Garbers D.L. Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice. J Clin Invest 100 (1997) 1590-1595
12. Carrithers S.L., Parkinson S.J., Goldstein S., Park P., Robertson D.C., and Waldman S.A. Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology 107 (1994) 1653-1661
13. Luongo C., Moser A.R., Gledhill S., and Dove W.F. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54 (1994) 5947-5952
14. Takahashi M., Nakatsugi S., Sugimura T., and Wakabayashi K. Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 21 (2000) 1117-1120
15. Sedgwick B. Repairing DNA-methylation damage. Nat Rev Mol Cell Biol 5 (2004) 148-157
16. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., and Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275 (1997) 1784-1787
17. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
18. Dimitrova N., and de Lange T. MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres. Genes Dev 20 (2006) 3238-3243
19. Luongo C., Gould K.A., Su L.K., Kinzler K.W., Vogelstein B., Dietrich W., Lander E.S., and Moser A.R. Mapping of multiple intestinal neoplasia (Min) to proximal chromosome 18 of the mouse. Genomics 15 (1993) 3-8
20. Haigis K.M., Caya J.G., Reichelderfer M., and Dove W.F. Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc Natl Acad Sci U S A 99 (2002) 8927-8931
21. Morin P.J., Vogelstein B., and Kinzler K.W. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A 93 (1996) 7950-7954
22. Zhang T., Otevrel T., Gao Z., Gao Z., Ehrlich S.M., Fields J.Z., and Boman B.M. Evidence that APC regulates surviving expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61 (2001) 8664-8667
23. Thompson W.J., Piazza G.A., Li H., Liu L., Fetter J., Zhu B., Sperl G., Ahnen D., and Pamukcu R. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res 60 (2000) 3338-3342
24. Aoki K., Tamai Y., Horiike S., Oshima M., and Taketo M.M. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat Genet 35 (2003) 323-330
25. Spruck C.H., Won K.A., and Reed S.I. Deregulated cyclin E induces chromosome instability. Nature 401 (1999) 297-300
26. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
27. Massague J. G1 cell-cycle control and cancer. Nature 432 (2004) 298-306
28. Shih I.M., Zhou W., Goodman S.N., Lengauer C., Kinzler K.W., and Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61 (2001) 818-822
29. Araki D., Uzawa K., Watanabe T., Shiiba M., Miyakawa A., Yokoe H., and Tanzawa H. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity. Int J Oncol 20 (2002) 355-360
30. Ogawa K., Utsunomiya T., Mimori K., Yamashita K., Okamoto M., Tanaka F., Inoue H., Ikeda Y., Saku M., Murayama S., and Mori M. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application. Int J Oncol 27 (2005) 417-426
31. Fodde R., Kuipers J., Rosenberg C., Smits R., Kielman M., Gaspar C., van Es J.H., Breukel C., Wiegant J., Giles R.H., and Clevers H. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3 (2001) 433-438
32. Rajagopalan H., Nowak M.A., Vogelstein B., and Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3 (2003) 695-701
33. Schulz S., Hyslop T., Haaf J., Bonaccorso C., Nielsen K., Witek M.E., Birbe R., Palazzo J., Weinberg D., and Waldman S.A. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer. Clin Cancer Res 12 (2006) 4545-4552
34. Witek M.E., Nielsen K., Walters R., Hyslop T., Palazzo J., Schulz S., and Waldman S.A. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Clin Cancer Res 11 (2005) 8549-8556
35. Birbe R., Palazzo J.P., Walters R., Weinberg D., Schulz S., and Waldman S.A. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Human Pathology 36 (2005) 170-179